latest news releases from the newsroom
Hemispherx Biopharma, Inc.
Hemispherx Biopharma Announces Interim Financial Results for the Three Months Ended September 30, 2007
PHILADELPHIA, Nov. 8, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its interim financial results for the three months ended September 30, 2007. The net loss for this fiscal quarter was approximately $5,718,000 or $(.08) per share compared to a loss of $3,807,000 or $(.06) per share for the same period in 2006. The $1,911,000 increase in loss was basically due to higher general and administrative expense of $2,232,000, primarily related to non-cash equity-based compensation expense. The results also reflect increased research and development costs of approximately $228,000, primarily related to independent consultants used in preparing and filing the New Drug Application (NDA) for the experimental therapeutic Ampligen(r) (Poly I: Poly C12U) to treat Chronic Fatigue Syndrome (CFS), offset by lower interest and financing costs of approximately $295,000 related to reduced debt and debt discount amortization. In July, the Company announced the retirement of all remaining debt related to convertible debentures issued in 2003 and 2004.
JetBlue Airways Corporation
Pack, Drop and Go! -- JetBlue Announces Remote Check-In and Bag Drop Service
NEW YORK, Nov. 8, 2007 (PRIME NEWSWIRE) -- JetBlue Airways (Nasdaq:JBLU) announces an expanded Remote Check-In service now available to customers onboard cruise ships. The cruise ship Remote Check-In program complements the service currently offered by the low-cost carrier at select hotels, convention centers, on-airport and off-airport parking areas, and rental car facilities in several cities across the nation and in the Caribbean.